Details for 2019214535
Up to date per 03.04.2026
Actions
Details for 2019214535
Granted/Registered
European Patent
13.05.2020 A
14.02.2024 B1
15.03.2013
US
201361792757 P
A61P 21/02 20060101AFI20200331BHEP
Owner
Tonix Pharma Limited3 Marine Road, Dun Laoghaire Dublin A96 HW25IE
Representative
Authorized Recipients
Dipl.-Ing. Gyorgy Pintzc/o Pintz & Partners LLC, Pf. 2451444 BudapestHU
Inventor
NEBULONI, Marinoc/o Redox snc Viale Stucchi 62/26 Monza (MB) 20052IT
COLOMBO, Patriziac/o Redox snc Viale Stucchi 62/26 Monza (MB) 20052IT
Information about Fees